THE ROADHOUSE PHARMACY: Bone Medical Ltd (ASX: BNE) has entered into a research agreement with William Harvey Research Limited (WHRL), to further study the company’s anti-inflammatory molecule for rheumatoid arthritis (RA), BN006, and support its progress towards clinical studies in man. WHRL is part of the William Harvey Research Institute in London and a world […]
THE DRILL SERGEANT: Paringa Resources (ASX: PNL) has announced the results of a JORC Code 2012 and NI43-101 compliant Scoping Study conducted on the north eastern quadrant of the company’s Buck Creek thermal coal project in Kentucky, USA. The study used the projects current coal Resource Estimate of 154 million tons of coal, and determined […]
THE DRILL SERGEANT: Navarre Minerals (ASX: NML) has announced further gold and copper results from the final batch of samples it has received from a recent 11 hole Reverse Circulation (RC) drilling program carried out at the company’s 100 per cent‐owned Eclipse copper‐gold prospect, located northwest of Melbourne in the Miga Arc copper belt. Navarre […]
WHAT THE BROKERS SAY: Interesting news and views from across the Resource Analyst universe. Website: www.breakawayresearch.com TNG Limited (ASX: TNG) TNG Limited (ASX: TNG) has made considerable progress over its portfolio of development and exploration projects, and has developed a two-pronged strategy, with the focus on its ferrous and strategic metals projects, with value adding […]
THE FUND RAISER: There’s been some happy explorers boosting their coffers this week. Placement and Entitlement Offer to raise $18.2 million Phoenix Gold (ASX: PXG) signalled its intention to raise new equity of up to $18.2 million (before costs) via an institutional placement of approximately 60 million shares to raise up to approximately $7.8 million […]
THE ROADHOUSE PHARMACIST: Starpharma (ASX: SPL) has been granted regulatory certification for marketing of the company’s VivaGel®‐coated condom in Japan. Starphama explained VivaGel® is licensed to Okamoto Industries as a condom coating for the Japanese market. Japan is the world’s second largest condom market and Okamoto is the market leader for condoms sold in the […]
THE PHARMACY: There’s a great deal of interest in the Bio-tech sector at the moment, so we have opened our own Pharmacy to keep our readers up to speed. OncoSil Medical commences Pivotal Clinical Trial OncoSil Medical (ASX: OSL) has commenced its Pivotal Clinical Trial for its OncoSil™ localised radiation therapy for the treatment […]
THE ROADHOUSE PHARMACIST: Unilife Corporation (ASX: UNS) has entered into a $60 million debt financing agreement with an affiliate of healthcare sector investment firm OrbiMed. Unilife said $40 million was funded to Unilife at the closing of the deal. Under the terms of the agreement, provided Unilife is in compliance, two additional tranches of $10 […]
THE PHARMACY: Viralytics Limited (ASX: VLA) has completed a $27.1 million equity offering that included a number of new institutional investors who specialize in healthcare. The offering was finalised after approval by shareholders at the company’s general meeting on 6 March 2014. The major participants in the placement were United States-based Cormorant Asset Management, which […]
THE PHARMACY: Antisense Therapeutics (ASX: ANP) has commenced dosing in its Phase I Stem Cell Mobilisation (SCM) Human Proof of Concept trial of ATL1102, the company’s second generation antisense drug targeting the VLA-4 receptor. Antisense said the trial will assess the safety, tolerability and effect of ATL1102 on the release of hematopoietic stem cells (CD34+) […]
